Puchta Alicja, Verschoor Chris P, Thurn Tanja, Bowdish Dawn M E
Department of Pathology and Molecule Medicine, McMaster University.
J Vis Exp. 2014 Jan 17(83):e50490. doi: 10.3791/50490.
Nasopharyngeal colonization by Streptococcus pneumoniae is a prerequisite to invasion to the lungs or bloodstream(1). This organism is capable of colonizing the mucosal surface of the nasopharynx, where it can reside, multiply and eventually overcome host defences to invade to other tissues of the host. Establishment of an infection in the normally lower respiratory tract results in pneumonia. Alternatively, the bacteria can disseminate into the bloodstream causing bacteraemia, which is associated with high mortality rates(2), or else lead directly to the development of pneumococcal meningitis. Understanding the kinetics of, and immune responses to, nasopharyngeal colonization is an important aspect of S. pneumoniae infection models. Our mouse model of intranasal colonization is adapted from human models(3) and has been used by multiple research groups in the study of host-pathogen responses in the nasopharynx(4-7). In the first part of the model, we use a clinical isolate of S. pneumoniae to establish a self-limiting bacterial colonization that is similar to carriage events in human adults. The procedure detailed herein involves preparation of a bacterial inoculum, followed by the establishment of a colonization event through delivery of the inoculum via an intranasal route of administration. Resident macrophages are the predominant cell type in the nasopharynx during the steady state. Typically, there are few lymphocytes present in uninfected mice(8), however mucosal colonization will lead to low- to high-grade inflammation (depending on the virulence of the bacterial species and strain) that will result in an immune response and the subsequent recruitment of host immune cells. These cells can be isolated by a lavage of the tracheal contents through the nares, and correlated to the density of colonization bacteria to better understand the kinetics of the infection.
肺炎链球菌在鼻咽部的定植是其侵入肺部或血液的前提条件(1)。这种微生物能够在鼻咽部的黏膜表面定植,在那里它可以存活、繁殖,并最终突破宿主防御机制侵入宿主的其他组织。在通常为下呼吸道的部位建立感染会导致肺炎。另外,细菌可扩散至血液中引起菌血症,这与高死亡率相关(2),或者直接导致肺炎球菌性脑膜炎的发生。了解鼻咽部定植的动力学以及对其的免疫反应是肺炎链球菌感染模型的一个重要方面。我们的鼻内定植小鼠模型是根据人类模型改编的(3),已被多个研究小组用于研究鼻咽部的宿主-病原体反应(4-7)。在该模型的第一部分,我们使用肺炎链球菌的临床分离株建立一种自限性细菌定植,这类似于人类成年人的带菌情况。本文详细描述的操作过程包括制备细菌接种物,然后通过鼻内给药途径接种接种物来建立定植过程。在稳态期间巨噬细胞是鼻咽部的主要细胞类型。通常,未感染的小鼠体内淋巴细胞很少(8),然而黏膜定植会导致低度至高度炎症(取决于细菌种类和菌株的毒力),这将引发免疫反应并随后招募宿主免疫细胞。这些细胞可以通过经鼻孔冲洗气管内容物来分离,并与定植细菌的密度相关联,以更好地了解感染的动力学。